Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 3141 Skin Neoplasms 554 Lymphoma, T-Cell, Cutaneous 543 Carcinoma, Non-Small-Cell Lung 421 Neoplasms 388 Mycosis Fungoides 369 Breast Neoplasms 364 Carcinoma, Basal Cell 360 Keratosis, Actinic 335 Sezary Syndrome 331 Lymphoma, Non-Hodgkin 312 Carcinoma, Renal Cell 308 Neoplasm Metastasis 304 Lymphoma 300 Leukemia, Lymphocytic, Chronic, B-Cell 292 Lymphoma, Large B-Cell, Diffuse 287 Lymphoma, Follicular 286 Hodgkin Disease 275 Uveal Melanoma 274 Lymphoma, B-Cell, Marginal Zone 273 Lymphoma, Mantle-Cell 272 Precursor Cell Lymphoblastic Leukemia-Lymphoma 271 Burkitt Lymphoma 258 Lymphoma, Large-Cell, Immunoblastic 248 Lung Neoplasms 236 Colorectal Neoplasms 232 Ovarian Neoplasms 214 Lymphoma, Large-Cell, Anaplastic 206 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 203 Multiple Myeloma 199

Interventions

camrelizumab 1 apatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Mucosal Melanoma × Dermatologic × Clear all

NCT03986515 2019-06-14

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Henan Cancer Hospital

Phase 2 Unknown

Mucosal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡